Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT01433315
Evidence suggests a relationship between sleep deprivation and cardiovascular disease. The investigators wish to determine whether 9 nights of modest sleep restriction results in activation of cardiovascular disease mechanisms, thus potentially increasing the risk of cardiovascular disease. The investigators hypothesize that sleep restriction will result in elevated blood pressure, inflammation, and neurocognitive deficits.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Evidence suggests a relationship between sleep deprivation and cardiovascular disease. Voluntary sleep restriction is common, with 28% of the US adult population reports getting 6 or fewer hours of sleep per night, and those who do are 24% more likely to have cardiovascular disease and have twice the risk of hypertension. Insufficient sleep may conceivably be one of the most common, and most preventable, cardiovascular risk factors. The investigators wish to determine whether 9 nights of modest sleep restriction results in activation of cardiovascular disease mechanisms, thus potentially increasing the risk of cardiovascular disease. The investigators will combine our cardiovascular studies with state-of-the art sleep monitoring and neurocognitive tests to provide unambiguous data on the physiologic effects of sleep restriction. Together, the investigators findings will help explain whether the reduced sleep duration in the general population may be contributing to the current epidemic of cardiovascular disease, and suggest strategies to reduce this risk.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
restricted sleep
Time frame: throughout 16 days
Change in mean arterial blood pressure over 24 hours, measured during acclimation, experimental, and recovery timepoints over the study period.
Time frame: throughout 16 days
Change in catecholamines, measured during acclimation, experimental, and recovery
Time frame: throughout 16 days
Change in endothelial function, measured during acclimation, experimental, and recovery timepoints.
Time frame: throughout 16 days
Change in baroreflex sensitivity, measured during acclimation, experimental, and recovery
Time frame: throughout 16 days
Change in arterial stiffness, measured during acclimation, experimental, and recovery timepoints.
Time frame: throughout 16 days
Change in electrocardiographic characteristics, measured during acclimation, experimental, and recovery timepoints.
Time frame: throughout 16 days
Change in markers of inflammation, measured during acclimation, experimental, and recovery timepoints.
Time frame: throughout 16 days
Change in fat tissue characteristics, determined by analysis of a fat biopsy sample.
Time frame: throughout 16 days
Change in sleep architecture and sleepiness, measured during acclimation, experimental, and recovery timepoints.
Time frame: throughout 16 days
Change in neurocognitive function, measured during acclimation, experimental, and recovery timepoints
Time frame: throughout 16 days
Change in cardiovascular reactivity, measured during acclimation, experimental, and recovery timepoints.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07495592
Cognitive, Dyssomnias
Tampa, Florida, United States
View Trial DetailsNCT05381532
Dyssomnias, Mental Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03747367
Chronobiology Disorders, Circadian Dysregulation
Boulder, Colorado, United States
View Trial Details